跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 43,514 条关于
“advanced RCC”
全部
43,514
临床试验
29,789
药物
522
机构
173
资讯
13,030
去年
Experts Discuss Treatment Strategies for Advanced RCC: Focus on Nivolumab-Ipilimumab Combination
去年
Advancements in Renal Cell Carcinoma Treatment: Immunotherapy Combinations and Personalized Approaches
2年前
Abemaciclib Monotherapy Fails to Show Efficacy in Advanced Renal Cell Carcinoma
2年前
Benmelstobart Plus Anlotinib Shows Superior Outcomes in Advanced Renal Cell Carcinoma
去年
TiNivo-2 Trial Highlights Challenges in ICI Retreatment for Advanced RCC
去年
Nivolumab Plus Ipilimumab Shows Durable Survival Benefit in Advanced RCC
去年
Cabozantinib-Nivolumab-Ipilimumab Combination for Advanced RCC Shows Sustained Benefits with Critical Safety Considerations
去年
CheckMate-9ER: Glycoproteomic Analysis Identifies Potential Biomarkers for Nivolumab Plus Cabozantinib in Advanced RCC
2年前
Belzutifan Shows Durable PFS and ORR in Advanced Clear Cell RCC
2年前
TiNivo-2 Trial: Nivolumab Fails to Improve Outcomes in Advanced RCC After Prior ICI Therapy
第 1 页,共 1303 页
上一页
下一页